^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    BIOMARKER:

    KRAS exon 13 mutation

    i
    Other names: KRAS, KRAS1, KRAS2, Kirsten rat sarcoma viral oncogene homolog
    Entrez ID:
    3845
    Related biomarkers:
    Expression
    Mutation
    CNA
    Others
    Related tests:
    over3years
    [VIRTUAL] Concurrent EGFR and KRAS Mutations in Lung Adenocarcinoma: A Single Institution Case Series (IASLC-WCLC 2020)
    Further studies are necessary to determine the most effective therapeutic strategies to address this unique subset of lung cancer patients. KRAS inhibitors are currently under study.
    Clinical • PD(L)-1 Biomarker • IO biomarker
    |
    EGFR (Epidermal growth factor receptor) • PD-L1 (Programmed death ligand 1) • KRAS (KRAS proto-oncogene GTPase) • MET (MET proto-oncogene, receptor tyrosine kinase)
    |
    PD-L1 expression • KRAS mutation • EGFR mutation • EGFR L858R • MET amplification • KRAS G12D • EGFR exon 21 mutation • KRAS G12 • KRAS G12S • EGFR exon 18 mutation • EGFR mutation + KRAS mutation • KRAS exon 13 mutation